Table 2.
Procedural data and postoperative outcomes in the transcatheter aortic valve replacement (TAVR) population
| Variable | TAVR (n = 171) |
|---|---|
| Access | |
| Transfemoral | 123 (72) |
| Alternative | 48 (28) |
| Predilatation | 76 (51) |
| Postdilatation | 21 (12) |
| TAVR valve-in-valve | 4 (2) |
| Valve type | |
| Balloon-expandable | 128 (75) |
| Self-expanding | 43 (25) |
| Valve size, mm | |
| 20–23 | 51 (30) |
| 25–26 | 77 (45) |
| 27–29 | 38 (22) |
| 34 | 5 (3) |
| Hospital LOS, d | 5 (3–7) |
| Postoperative echocardiographic data | |
| LVEF, % | 53 ± 12 |
| AVA, m2 (n = 137) | 1.62 ± 0.51 |
| Mean gradient, mm Hg | 10 ± 5 |
| Pulmonary systolic arterial pressure, mm Hg | 45 ± 14 |
| Complications at 30 d | |
| Death | 11 (6) |
| Stroke/TIA | 9 (5) |
| Surgical conversion | 5 (3) |
| Significant periprosthetic insufficiency | 5 (3) |
| Pacemaker implantation | 7 (5) |
| Acute kidney insufficiency | 14 (8) |
| Pulmonary embolus | 3 (2) |
| Pleural effusion | 4 (2) |
| Heart conduction deficits/arrythmias | |
| Atrioventricular block | 15 (9) |
| Atrial fibrillation de novo | 11 (6) |
| Left bundle block | 22 (13) |
Values are mean ± standard deviation, median (25th-75th percentile), or n (%).
AVA, aortic valve area; LOS, length of stay; LVEF, left ventricular ejection fraction; TIA, transient ischemic attack.